beam me up scottieBuy $4 dollar stock. Sell $7 or $12. place Stop loss 0.50c below the dashed-line for your protection. Live-Laugh-Love. Let's make 2024 great.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.66USD
−156.23 MUSD
512.35 MUSD
40.65 M
About Bioventus Inc.
Sector
Industry
CEO
Robert Claypoole
Website
Headquarters
Durham
Founded
2011
FIGI
BBG00D8550B3
Bioventus, Inc. is a medical technology company, which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. The Active Healing Therapies-U.S and International offers two types of non-surgical products which are non-invasive exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief. The Surgical segment offers a portfolio of advanced bone graft substitutes. The BMP segment comprises proprietary next-generation bone morphogenetic protein, or BMP. The company was founded on November 23, 2011 and is headquartered in Durham, NC.
BVS: Bioventus – Innovations and Growth in Medical TechnologiesBioventus Inc. (Nasdaq:BVS) , a company specializing in medical devices and active treatments, has demonstrated significant achievements despite challenges. Recent research and company decisions indicate potential for further growth and innovations in the healthcare sector.
The company recently rep
$BVS: Bioventus is a $45 TargetI believe the price target for Bioventus can easily be $45. It is a new IPO for a company w/ 700+ employees, disruptive orthobiologics and surgical methods, and high growth potential. Support just needs to pickup. That said, please do your own due diligence and invest at your own risk. Everything I
$BVS is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Bioventus is a global medical device company focused on developing and commercializing clinically differentiated, cost efficient and minimally invasive treatments that engage and enhance the body’s natural healing process.
The share price is rising and gonna cont
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BVS is 13.57 USD — it has increased by 2.03% in the past 24 hours. Watch Bioventus Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Bioventus Inc. stocks are traded under the ticker BVS.
BVS stock has risen by 5.19% compared to the previous week, the month change is a 16.17% rise, over the last year Bioventus Inc. has showed a 267.75% increase.
We've gathered analysts' opinions on Bioventus Inc. future price: according to them, BVS price has a max estimate of 17.00 USD and a min estimate of 8.00 USD. Watch BVS chart and read a more detailed Bioventus Inc. stock forecast: see what analysts think of Bioventus Inc. and suggest that you do with its stocks.
BVS stock is 2.02% volatile and has beta coefficient of 1.96. Track Bioventus Inc. stock price on the chart and check out the list of the most volatile stocks — is Bioventus Inc. there?
Today Bioventus Inc. has the market capitalization of 883.74 M, it has increased by 1.72% over the last week.
Yes, you can track Bioventus Inc. financials in yearly and quarterly reports right on TradingView.
Bioventus Inc. is going to release the next earnings report on Nov 5, 2024. Keep track of upcoming events with our Earnings Calendar.
BVS earnings for the last quarter are 0.19 USD per share, whereas the estimation was 0.07 USD resulting in a 182.60% surprise. The estimated earnings for the next quarter are 0.02 USD per share. See more details about Bioventus Inc. earnings.
Bioventus Inc. revenue for the last quarter amounts to 151.22 M USD, despite the estimated figure of 137.60 M USD. In the next quarter, revenue is expected to reach 133.24 M USD.
BVS net income for the last quarter is −23.99 M USD, while the quarter before that showed −4.57 M USD of net income which accounts for −424.99% change. Track more Bioventus Inc. financial stats to get the full picture.
No, BVS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 1, 2024, the company has 970.00 employees. See our rating of the largest employees — is Bioventus Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bioventus Inc. EBITDA is 74.28 M USD, and current EBITDA margin is 14.32%. See more stats in Bioventus Inc. financial statements.
Like other stocks, BVS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bioventus Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bioventus Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bioventus Inc. stock shows the strong buy signal. See more of Bioventus Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.